Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.68 |
| ▸ | BACE2 | Q9Y5Z0 | 16/20 | 0.68 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10328853 | 0.91 | BACE1 (0.68) | BACE1BACE2CTSD | |
| SCHEMBL17327443 | 0.90 | BACE1 (0.68) | BACE1BACE2CTSD | |
| SCHEMBL17327471 | 0.89 | BACE1 (0.69) | BACE1BACE2 | |
| SCHEMBL17327353 | 0.87 | BACE1 (0.67) | BACE1BACE2 | |
| SCHEMBL10328891 | 0.85 | BACE1 (0.60) | BACE1BACE2CTSD | |
| SCHEMBL10328898 | 0.85 | BACE1 (0.63) | BACE1BACE2CTSD | |
| SCHEMBL17327430 | 0.85 | BACE1 (0.68) | BACE1BACE2CTSD | |
| SCHEMBL17327351 | 0.84 | BACE1 (0.69) | BACE1BACE2CTSD | |
| SCHEMBL10329010 | 0.84 | BACE1 (0.60) | BACE1BACE2CTSD | |
| SCHEMBL10330001 | 0.84 | BACE1 (0.60) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2931284-B1 | BACE INHIBITORS OF IMINOTHIADIAZINE DIOXIDES | MERCK SHARP & DOHME (US) | 2017-08-23 | — | — | EP | disclosed |
| US-9447085-B2 | Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use | MERCK SHARP & DOHME CORP. (US) | 2016-09-20 | — | — | US | disclosed |
| US-20150353516-A1 | IMINOTHIADIAZINE DIOXIDES CONTAINING A THIOAMIDE, AMIDINE, OR AMIDE OXIME GROUP AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME LLC | 2015-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353516-A1 | IMINOTHIADIAZINE DIOXIDES CONTAINING A THIOAMIDE, AMIDINE, OR AMIDE OXIME GROUP AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | BACE2, BACE1, APP | BACE1 2/4885BACE2 1/4885CTSD 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.